Company Financials

Lotus Pharmaceutical Co. Ltd Financials

Taiwan dollar

business Lotus Pharmaceutical Co. Ltd Company Profile

Main Stock Listing

TWSE: 1795

Market Capitalization TW$74.13 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 15.64
Forward PE 10.32
Price to Sales TTM TW$3.97
Price to Book MRQ TW$3.34
Enterprise to Revenue 4.34
Enterprise to EBITDA 11.77

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 25.36%
Operating Margin 25.00%
Return on Assets TTM 9.09%
Return on Equity TTM 22.32%

Income Statement

Revenue TTM TW$18,656,458,752
Revenue per Share TTM TW$71.51
Quarterly Revenue Growth -8.90%
Gross Profit TTM TW$10,869,031,936
EBITDA TW$7,846,981,000
Net Income to Common TTM TW$4,730,935,808
Diluted EPS TTM TW$18.03
Quarterly Earnings Growth YoY -8.30%

Balance Sheet

Total Cash MRQ TW$5,669,623,808
Total Cash per Share MRQ TW$21.56
Total Debt MRQ TW$
Total Debt to Equity MRQ 56.00
Current Ratio MRQ 1.81
Book Value per Share MRQ TW$84.31

Cash Flow

Operating Cash Flow TTM TW$7,678,982,144
Levered Free Cash Flow TTM TW$3,120,714,496

1795 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 261,749,812
Float Shares 160,827,926
Avg 10 Volume 1,598,913
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 48.33%
% Held by Institutions 10.74%

Stock Price Summary

Beta 0.17
Fifty Two Week Low TW$172.50
Fifty Two Week High TW$328.00
Fifty Two Week Change 4.61%
Day 50 MA TW$289.46
Day 200 MA TW$239.00

Dividends and Splits

Forward Annual Dividend Rate TW$5.78
Forward Annual Dividend Yield 2.04%
Trailing Annual Dividend Rate TW$5.78
Trailing Annual Dividend Yield 2.04%
Payout Ratio 32.03%
Dividend Date
Ex Dividend Date 2025-08-11
Last Split Factor
Last Split Date 2010-09-08